Novira Therapeutics Completes Series A Financing
Novira Therapeutics has completed a Series A financing after securing $7.5 million from new investor Versant Ventures. This brings the total raised from all investors in the round to $25 million. Versant joins 5AM Ventures and Canaan Partners, which led the first closing of the Series A in August 2012.
26 March 2013•3 mins read
